NCT04145349 2025-12-08CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell TumorEli Lilly and CompanyPhase 1/2 Active not recruiting30 enrolled 16 charts
NCT04901806 2024-03-28Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid TumorsPyramid BiosciencesPhase 1 Terminated29 enrolled
NCT03874455 2024-03-22Tazemetostat Expanded Access Program for Adults With Solid TumorsIpsenNo longer available
NCT03600649 2023-11-21Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related SarcomasSalarius Pharmaceuticals, LLCPhase 1 Unknown50 enrolled
NCT05266196 2023-08-01A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)Salarius Pharmaceuticals, LLCPhase 1/2 Unknown10 enrolled
NCT02982941 2022-02-08Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid TumorsMacroGenicsPhase 1 Completed25 enrolled
NCT00055952 2012-05-16Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell TumorDaiichi SankyoPhase 2 Completed